Primary generalized AL amyloidosis

Kogan E.A.

Sechenov First Moscow State Medical University

ORCID: 0000-0003-1775-3060

Saltykov B.B.

Sechenov First Moscow State Medical University

Atanov P.V.

Sechenov First Moscow State Medical University

Primary generalized AL amyloidosis

Authors:

Kogan E.A., Saltykov B.B., Atanov P.V.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2021;83(1): 31‑34

DOI: 10.17116/patol20218301131

Downloaded: 177

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Kogan EA, Saltykov BB, Atanov PV. Primary generalized AL amyloidosis. Russian Journal of Archive of Pathology. 2021;83(1):31‑34. (In Russ.)
https://doi.org/10.17116/patol20218301131

Подписка 2025 (Russian Journal of Archive of Pathology)

Close metadata

Recommended articles:

Lung pathology in children with a long-term novel coronavirus infection COVID-19. Russian Journal of Archive of Pathology. 2024;(1):36-43

Cardiac myxoma: biological features, morphology, differential diagnosis. Russian Journal of Archive of Pathology. 2024;(6):74-81

Bilateral vestibulopathy and sensorineural hearing loss in necrobiotic xanthogranuloma, multiple myeloma and amiloidosis. Russian Bulletin of Otorhinolaryngology. 2024;(2):82-87

Evaluation of therapeutic efficiency of the combined nasal spray containing hyaluronic acid and alpha-tocopherol in postoperative period after endonasal surgery. Russian Rhinology. 2024;(4):283-295

The paper describes an autopsy observation of a 71-year-old male with primary generalized AL amyloidosis lasting about 4 months after its manifestation to the onset of death from hepatic and renal failure. Total damage to the liver and spleen, as well as amyloid deposits in the kidneys, adrenal glands, and pancreas were noted.

Keywords:

primary generalized AL amyloidosis

morphology

Authors:

Kogan E.A.

Sechenov First Moscow State Medical University

ORCID: 0000-0003-1775-3060

Saltykov B.B.

Sechenov First Moscow State Medical University

Atanov P.V.

Sechenov First Moscow State Medical University

Received:

09.08.2020

Accepted:

16.11.2020

List of references:

Pal’tsev MA, Kakturskii LV, Zairat’yants OV, eds. Patologicheskaya anatomiya. Natsional’noe rukovodstvo. M.: GEOTAR-Media; 2011. (In Russ.).
Guo YM, Takahashi N, Miyabe K, Yoshida M, Abe F, Yamashita T, Nara M, Yoshioka T, Ohashi K, Goto A, Takahashi N. Immunoglobulin light chain amyloidosiswith severe liver dysfunction accompanied by factor X deficiency. Intern Med. 2019;58(20):3039-3043. https://doi.org/10.2169/internalmedicine.2864-19
Tret’yakov AYu, Zakharchenko SP, Tret’yakova VA, Ermilov OV, Shekhovtsov SA, Khabibulin RR, Aleinikova KS, Dan VS, Leshcheva NA. Clinical observation of a combination of diffuse alveololar-septal pulmonary lesion and amyloid cardiomyopathy in systemic AL-amiloidosis in the elderly. Terapevticheskii arkhiv. 2018;90(12):96-100. (In Russ.).
Varga C, Titus SE, Toskic D, Comenzo RL. Use of novel therapies in the treatment of light chain amyloidosis. Blood Rev. 2019;37:100581.
Naiki H, Sekijima Y, Ueda M, Ohashi K, Hoshii Y, Shimoda M, Ando Y. Human amyloidosis still intractable but becoming curable: The essential role of pathological diagnosis in the selection of type-specific therapeutics. Pathol Int. 2020;70(4):191-198.
Paukov VS, ed. Klinicheskaya patologiya. Rukovodstvo dlya vrachey. M.: Litterra; 2018. (In Russ.).
Muchtar E, Dispenzieri A, Leung N, Lacy MQ, Buadi FK, Dingli D, Grogan M, Hayman SR, Kapoor P, Hwa YL, et al. Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria. Amyloid. 2019;26(suppl 1):101-102. ttps://doi.org/10.1080/13506129.2019.1582486
D’Souza A, Magnus BE, Myers J, Dispenzieri A, Flynn KE. The use of PROMIS patient-reported outcomes (PROs) to inform light chain (AL) amyloid disease severity at diagnosis. Amyloid. 2020;27(2):111-118. https://doi.org/10.1080/13506129.2020.1713743

Close metadata